OR WAIT null SECS
Cheryl Barton is director of PharmaVision, info@pharmavision.co.uk.
June 05, 2024
EMA is promoting the use of RWD in decision-making and has started a public consultation to review its draft recommendations.
May 07, 2024
Novel delivery technologies enhance brain penetration to target neurodegenerative diseases and glioblastomas.
April 02, 2024
The European pharma industry needs to be prepared for the new clinical data requirements.
March 02, 2024
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 02, 2024
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
January 03, 2024
Novel molecular glues are transforming targeted protein degradation.